Treatment and prevention of bacterial skin infections using oritavancin
AssigneeThe Medicines Company
InventorsGreg MOECK, Theresa MATKOVITS, Stephan A. BILLSTEIN, Gina EAGLE, Ketna PATEL, Francis F. ARHIN
Life of this patent
Estimating the term…
Abstract
Methods for the treatment and prevention of bacterial skin infections using the glycopeptide antibiotic oritavancin are disclosed.
Claims23
1-50. (canceled)
A method of treating or preventing a skin lesion in a subject, comprising administering a therapeutically effective amount of a pharmaceutical composition comprising oritavancin or a pharmaceutically acceptable salt thereof to a subject having a skin lesion or at risk of developing a skin lesion, thereby treating or preventing a skin lesion in a subject.
A method of reducing the size of a skin lesion in a subject, comprising administering a therapeutically effective amount of a pharmaceutical composition comprising oritavancin or a pharmaceutically acceptable salt thereof to a subject having a skin lesion, thereby reducing the size of a skin lesion in a subject.
72-96. (canceled)
Dependencies are inferred from the claim text.